editorial gsk plant for new anti hiv drug |
||||||||||||||||||||||||||||||||||||||||
| navigate by keyword : aids amato anti company drug editorial europe fostemsavir general glaxosmithkline global gsk healthcare hiv hub inauguration innovative italy majority manager maurizio netherlands new opens owned parma patients pfizer plant polo produce resistant san shareholders shionogi speaks specialist torrile treatment viiv |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| San Polo di Torrile, Italy - October 12, 2018: Maurizio Amato, General Manager Hub ViiV Italy & Netherlands speaks at the inauguration of the plant to produce Fostemsavir, innovative anti-HIV drug |
||||||||||||||||||||||||||||||||||||||||
|
Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners. |
||||||||||||||||||||||||||||||||||||||||